Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge.
Jakielaszek C, Hilliard JJ, Mannino F, Hossain M, Qian L, Fishman C, Chou YL, Henning L, Novak J, Demons S, Hershfield J, O'Dwyer K. Jakielaszek C, et al. Among authors: novak j. Antimicrob Agents Chemother. 2023 May 17;67(5):e0138122. doi: 10.1128/aac.01381-22. Epub 2023 Apr 25. Antimicrob Agents Chemother. 2023. PMID: 37097147 Free PMC article.
Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
Hilliard JJ, Jakielaszek C, Mannino F, Hossain M, Qian L, Fishman C, Demons S, Hershfield J, Soffler C, Russo R, Henning L, Novak J, O'Dwyer K. Hilliard JJ, et al. Among authors: novak j. Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0149723. doi: 10.1128/aac.01497-23. Epub 2024 Feb 15. Antimicrob Agents Chemother. 2024. PMID: 38358266 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
Publisher Correction: Glycosylation in health and disease.
Reily C, Stewart TJ, Renfrow MB, Novak J. Reily C, et al. Among authors: novak j. Nat Rev Nephrol. 2024 Dec 12. doi: 10.1038/s41581-024-00923-0. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 39668240 No abstract available.
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance.
Bock AM, Wenzl K, Novak JP, Stokes ME, Hopper MA, Krull JE, Dropik AR, Sarangi V, Ortiz M, Stong N, Huang CC, Maurer MJ, King RL, Farooq U, Wang Y, Witzig TE, Ansell SM, Habermann TM, Cerhan JR, Gandhi AK, Nowakowski G, Novak AJ. Bock AM, et al. Among authors: novak jp. Hematol Oncol. 2025 Jan;43(1):e70006. doi: 10.1002/hon.70006. Hematol Oncol. 2025. PMID: 39612356 Free PMC article.
2,208 results